title: Cell and gene therapy in Australia.
abstract: The expansion of human cells to produce cell therapeutic products for the treatment of disease is, with few exceptions, an experimental therapy. Because cell therapies involve a biological product, often with some genetic or other modification, they require extensive pre-clinical research and development. Cell therapy production processes and premises require licensing by the Therapeutic Goods Administration. In this review, timed to coincide with the international meetings of the ISCT and ISSCR in Australia, we describe some promising cell therapies currently under development.
authors.affiliation: Cell and Molecular Therapy Laboratories, Sydney Cancer Centre, Royal Prince Alfred Hospital, Centenary Institute of Cancer Medicine and Cell Biology, Department of Experimental Medicine, The University of Sydney, Sydney, Australia.
authors.forename: R
authors.initials: R
authors.lastname: Martiniello-Wilks
authors.forename: J E J
authors.initials: JE
authors.lastname: Rasko
mesh_terms: D001315:Australia; D017690:Cell Transplantation; D002986:Clinical Trials as Topic; D015316:Genetic Therapy; D006801:Humans; D007167:Immunotherapy; D012038:Regeneration; D014612:Vaccines / Q000627:therapeutic use
chemical_list: D014612:Vaccines